The Use of Microneedles in Photodynamic Therapy
The global aim of this study is to investigate how microneedles can facilitate the penetration and efficacy of photodynamic therapy in the treatment of actinic keratoses
The specific aims are as follows:
- Investigate whether pretreatment with microneedles enhances penetration of topical aminolevulinic acid (ALA) that is marketed as Levulan® Kerasticks by DUSA pharmaceuticals Inc.
- Investigate whether pretreatment with microneedles can decrease the required incubation times of the topical ALA prior to exposure to blue light photodynamic therapy.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Sacramento, California, United States, 95864
- UC Davis, Dermatology
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Subjects who are 18 and older
- Subjects who have at least 3 actinic keratoses on each side of the forehead
- Subjects who signed an IRB approved informed consent
Exclusion Criteria:
- Subjects who smoke
- Subjects who have a photosensitizing condition such as lupus, porphyria, or similar condition.
- Subjects who received a diagnosis of skin cancer on the face in past year
- Subjects who received field treatment for actinic keratoses to the face in the past 60 days
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: 20 minutes incubation - with pretreatment
|
The study device (Microchannel Skin System by 3M Company)is fabricated from medicalgrade polymer consisting of a rectangular array of 351 pyramidal, 700-μm-long, solid microneedles.
Other Names:
Levulan® Kerastick® DUSA Pharmaceuticals, Inc., Wilmington, MA
Blu-U unit (DUSA Pharmaceuticals, Inc., Wilmington, MA)
|
|
Experimental: 40 minutes incubation - with pretreatment
|
The study device (Microchannel Skin System by 3M Company)is fabricated from medicalgrade polymer consisting of a rectangular array of 351 pyramidal, 700-μm-long, solid microneedles.
Other Names:
Levulan® Kerastick® DUSA Pharmaceuticals, Inc., Wilmington, MA
Blu-U unit (DUSA Pharmaceuticals, Inc., Wilmington, MA)
|
|
Experimental: 60 minutes incubation - with pretreatment
|
The study device (Microchannel Skin System by 3M Company)is fabricated from medicalgrade polymer consisting of a rectangular array of 351 pyramidal, 700-μm-long, solid microneedles.
Other Names:
Levulan® Kerastick® DUSA Pharmaceuticals, Inc., Wilmington, MA
Blu-U unit (DUSA Pharmaceuticals, Inc., Wilmington, MA)
|
|
Sham Comparator: 60 minutes incubation - no pretreatment
|
Levulan® Kerastick® DUSA Pharmaceuticals, Inc., Wilmington, MA
Blu-U unit (DUSA Pharmaceuticals, Inc., Wilmington, MA)
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Actinic Keratoses Reduction Percent
Time Frame: one month after treatment
|
one month after treatment
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 282150
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.